Published in J Pain on August 08, 2009
Altering Lipids for Tolerance of Aromatase Inhibitor Therapy (ALTA) | NCT04268134
Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain (2012) 1.94
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol (2012) 1.91
Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study. Cancer (2015) 1.80
Identifying treatment responders and predictors of improvement after cognitive-behavioral therapy for juvenile fibromyalgia. Pain (2014) 1.50
Pain assessment using the NIH Toolbox. Neurology (2013) 1.23
Are Modic changes prognostic for recovery in a cohort of patients with non-specific low back pain? Eur Spine J (2011) 0.97
Single-lead percutaneous peripheral nerve stimulation for the treatment of hemiplegic shoulder pain: a case report. Arch Phys Med Rehabil (2011) 0.95
Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System. J Pain Symptom Manage (2015) 0.91
Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis. Drug Des Devel Ther (2015) 0.91
Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements? Support Care Cancer (2014) 0.91
Advances in clinical research methodology for pain clinical trials. Nat Med (2010) 0.86
Investigation of central pain processing in postoperative shoulder pain and disability. Clin J Pain (2014) 0.83
A community pain service solution-focused pain management programme: delivery and preliminary outcome data. Br J Pain (2014) 0.81
Efficacy of Duloxetine in Patients with Chronic Pain Conditions. Curr Drug ther (2011) 0.81
A pilot trial of intravenous pamidronate for chronic low back pain. Pain (2013) 0.80
Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome. Eur J Pain (2013) 0.80
Topical ambroxol for the treatment of neuropathic pain. An initial clinical observation. Schmerz (2015) 0.79
Assessing the response to opioids in cancer patients: a methodological proposal and the results. Support Care Cancer (2014) 0.78
Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study. Clin Res Cardiol (2011) 0.78
Steroid injections added to the usual treatment of lumbar radicular syndrome: a pragmatic randomized controlled trial in general practice. BMC Musculoskelet Disord (2014) 0.78
Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting. J Pain Res (2011) 0.77
Personalized symptom goals and response in patients with advanced cancer. Cancer (2016) 0.77
Acceptance and Commitment Therapy for chronic pain: A diary study of treatment process in relation to reliable change in disability. J Contextual Behav Sci (2014) 0.76
Dependence of the minimal clinically important improvement on the baseline value is a consequence of floor and ceiling effects and not different expectations by patients. J Clin Epidemiol (2014) 0.76
Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images. Exp Ther Med (2015) 0.75
Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain. Neuropsychiatr Dis Treat (2015) 0.75
Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia. Arthritis Res Ther (2013) 0.75
Temperament, Beliefs About Pain Control, and Pain Intensity in Endometriosis Patients. J Clin Psychol Med Settings (2016) 0.75
Efficacy of focused low-intensity pulsed ultrasound therapy for the management of knee osteoarthritis: a randomized, double blind, placebo-controlled trial. Sci Rep (2016) 0.75
Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo. Int J Clin Pract (2015) 0.75
Real-life efficacy of pregabalin for the treatment of peripheral neuropathic pain in daily clinical practice in Denmark: the NEP-TUNE study. J Pain Res (2016) 0.75
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. Breast Cancer Res Treat (2017) 0.75
Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials. J Pain Res (2017) 0.75
[Topical ambroxol for the treatment of neuropathic pain : A first clinical observation. German version]. Schmerz (2015) 0.75
A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis. J Pain Res (2017) 0.75
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant (2005) 19.83
A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med (2006) 5.74
Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care (2004) 4.39
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant (2006) 4.09
A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum (2005) 2.20
Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. Br J Psychiatry (2002) 2.20
Fibromyalgia syndrome. J Rheumatol (2007) 2.04
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med (2005) 1.99
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J Clin Microbiol (2005) 1.48
Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J Clin Microbiol (2002) 1.27
Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol (2003) 1.27
ToF-SIMS imaging and depth profiling of HeLa cells treated with bromodeoxyuridine. Surf Interface Anal (2011) 1.22
Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice. Cancer Res (2007) 1.18
Baseline observation carry forward: reasoning, properties, and practical issues. J Biopharm Stat (2009) 1.13
Conquering the Sahara and Arabian deserts: systematics and biogeography of Stenodactylus geckos (Reptilia: Gekkonidae). BMC Evol Biol (2012) 1.10
Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Curr Med Res Opin (2007) 1.09
Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? Int Clin Psychopharmacol (2006) 1.08
Familial eosinophilia: a benign disorder? Blood (2004) 1.08
Glycosylation of sputum mucins is altered in cystic fibrosis patients. Glycobiology (2007) 1.07
Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. Am J Respir Crit Care Med (2005) 1.07
Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. Int Clin Psychopharmacol (2011) 1.05
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Curr Med Res Opin (2007) 1.04
Recognition and labeling of delirium symptoms by intensivists: does it matter? Intensive Care Med (2007) 1.04
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram). Neuropsychobiology (2007) 1.04
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med (2007) 0.98
Early symptom change prediction of remission in depression treatment. Psychopharmacol Bull (2009) 0.95
Getting evidence into practice in developing countries. Evid Based Cardiovasc Med (2006) 0.93
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain. Pain Med (2007) 0.93
Intracerebral microdialysis during deep brain stimulation surgery. J Neurosci Methods (2010) 0.93
Identifying individual cell types in heterogeneous cultures using secondary ion mass spectrometry imaging with C60 etching and multivariate analysis. Anal Chem (2012) 0.92
Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol. Hum Psychopharmacol (2012) 0.92
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches. J Clin Psychopharmacol (2005) 0.91
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology (Berl) (2011) 0.91
Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain. Diabetes Care (2007) 0.90
Identification of a secreted fatty acid and retinol-binding protein (Hp-FAR-1) from Heligmosomoides polygyrus. J Nematol (2009) 0.89
Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation. Depress Anxiety (2007) 0.89
Influence of pain and depression on fear of falling, mobility, and balance in older male veterans. J Rehabil Res Dev (2007) 0.89
Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry (2002) 0.88
An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis. Mol Cell Proteomics (2005) 0.88
Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine. Int Clin Psychopharmacol (2008) 0.87
Measuring the school impact on child obesity. Soc Sci Med (2008) 0.86
Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range. J Psychiatr Res (2005) 0.86
Differences in gene expression profiles in dermal fibroblasts from control and patients with age-related macular degeneration elicited by oxidative injury. Free Radic Biol Med (2005) 0.85
Answers to the most common questions about the hepatic safety profile of duloxetine. Postgrad Med (2008) 0.85
Simple options for improving signal detection in antidepressant clinical trials. Psychopharmacol Bull (2007) 0.85
Effects of smoking, distraction, and gender on pain perception. Behav Med (2004) 0.85
A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol (2014) 0.84
A prospective baseline study of frail older people before the introduction of an intermediate care service. Health Soc Care Community (2005) 0.83
Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction. J Aerosol Med (2002) 0.83
Monoclonal antibodies to avian Escherichia coli Iss. Avian Dis (2003) 0.82
Effective smoking cessation interventions for COPD patients: a review of the evidence. JRSM Short Rep (2011) 0.82
Efficacy of Duloxetine in Patients with Chronic Pain Conditions. Curr Drug ther (2011) 0.81
A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol (2014) 0.81
Patterned surfaces combining polymer brushes and conducting polymer via colloidal template electropolymerization. Adv Mater (2011) 0.81
Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Clin J Pain (2009) 0.79
Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease. Alzheimer Dis Assoc Disord (2015) 0.78
Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions. J Diabetes Complications (2008) 0.78
VIP receptor 1 (VPAC1) promoter targets the expression of a reporter gene to cerebellum and adrenal medulla in transgenic mice. Regul Pept (2003) 0.78
Development of lipoprotein(a) siRNAs for mechanism of action studies in non-human primate models of atherosclerosis. J Cardiovasc Transl Res (2015) 0.77
The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder. Curr Med Res Opin (2008) 0.77
Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine. Clin Ther (2012) 0.77
Evaluation of sentinel node biopsy in locally advanced breast cancer patients who become clinically node-negative after neoadjuvant chemotherapy: a preliminary study. Int J Breast Cancer (2011) 0.77
Targeting of host cell lineages by vertically transmitted, feminising microsporidia. Int J Parasitol (2006) 0.76
Production of a recombinant version of a Heligmosomoides polygyrus antigen that is preferentially recognized by resistant mouse strains. Parasite Immunol (2002) 0.76
Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: a pilot study in a Sydney clinic. Respirology (2002) 0.76
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations. J Pain (2017) 0.75
The self's symbolic role in implicit approach/avoidance: movement time evidence. J Soc Psychol (2014) 0.75
Measuring fidelity to a culturally adapted HIV prevention intervention for men in substance abuse treatment. J Subst Abuse Treat (2013) 0.75
Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor. Eur J Med Chem (2007) 0.75
Have you cottoned on to real nappies? Pract Midwife (2008) 0.75
Addressing methodological issues in studying antidepressant onset efficacy using prespecified sensitivity analyses. Psychopharmacol Bull (2008) 0.75
Pharmacokinetics of orally administered duloxetine in children and adolescents with major depressive disorder. Clin Pharmacokinet (2014) 0.75
Over-representation of diabetic patients with renal anaemia in the primary care setting. Fam Pract (2009) 0.75
From Infancy to Adolescence: The Kansas University School of Medicine-Salina: A Rural Medical Campus Story. Acad Med (2016) 0.75
Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol (2015) 0.75
Climate sensitivity of gaseous elemental mercury dry deposition to plants: impacts of temperature, light intensity, and plant species. Environ Sci Technol (2010) 0.75
A team approach in palliative care: enhancing outcomes. S D J Med (2002) 0.75
Gastrocnemius Stretching Program: More Effective in Increasing Ankle/Rear-Foot Dorsiflexion When Subtalar Joint Positioned in Pronation Than in Supination. J Sport Rehabil (2014) 0.75
Intensity influence on Gaussian beam laser based measurements using quadrant photodiodes. Appl Opt (2010) 0.75
Mental Retardation Research Center: Children's Hospital of Philadelphia & University of Pennsylvania. Int J Dev Neurosci (2002) 0.75
Treating the war casualty: case reports of polytrauma. J Hand Ther (2008) 0.75
Manliness and Exploration: The Discovery of the North Pole. Osiris (2015) 0.75
Improving blood sugar control during critical illness: a cohort study. J Crit Care (2009) 0.75
Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studies. Int Clin Psychopharmacol (2013) 0.75
Predicting Low Back Pain Outcomes: Suggestions for Future Directions. J Orthop Sports Phys Ther (2017) 0.75
Novel targeted agents on the horizon for castration-resistant prostate cancer. Future Oncol (2010) 0.75